Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1684 | Thyroid (non-cancer) | ICEECE2012

A rare case of periodic hypokalaemic paralysis secondary to Graves’ thyrotoxicosis

Wernig F. , Wincup C. , Wynne K.

A 42-year-old gentleman of Ghanaian origin presented with a 1 month history of worsening severe proximal myopathy. On presentation his symptoms had progressed to the extent that he was unable to mobilise from his bed. Prior to this illness he had been fit and well. Examination revealed severe proximal myopathy and a uniformly enlarged, smooth thyroid gland. There was no clinical evidence of hyperthyroidism.Blood tests on admission showed a serum potassiu...

ea0029p1693 | Thyroid (non-cancer) | ICEECE2012

Exophtalmoses due to a bilateral lacrymal gland MALT lymphoma in first occurrence of Graves’disease

Solmon C. , Gisserot O. , Hammoutene D.

Introduction: Bilateral exophtalmoses is common at Graves’ disease diagnosis, but context and clinical abnormalities lead sometimes to consider other diagnosis.Case report: A 52-year-old man had a previous history of pulmonary MALT lymphoma in complete remission and Hashimoto’s thyroiditis, which were diagnosed simultaneously 6 years before. He presented recently with hyperthyroidism (TSH <0.001 mUI/l; T4=25 pmol/l) after 2 month...

ea0029p1753 | Thyroid cancer | ICEECE2012

The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer cells

Chu R , van Hasselt C , Chen G

Both of peroxisome proliferator-activated receptor gamma (PPARγ) and estrogen receptor (ER) contribute to the development of thyroid cancer. Previously, the activation of ERα was found to promote the proliferation of thyroid cancer cells, whereas activation of either ERβ or PPARγ resulted in apoptosis of thyroid cancer cells. Furthermore, a transactivation between ER and PPARγ was reported in estrogen-responsive malignancy, such as breast cancer. Howev...

ea0028p64 | Clinical practice/governance and case reports | SFEBES2012

Danazol falsely elevates oestradiol levels in a woman with ovarian failure

Devine K , Freel E , Perry C

A 29 year old woman with multiply-relapsed Hodgkin’s lymphoma became amenorrhoeic with vasomotor menopausal symptoms following multiple cycles of chemotherapy. Subsequent biochemistry confirmed primary gonadal failure (LH 30.7 U/L, FSH 49.9 U/L, oestradiol <70 pmol/L). Following allogeneic bone marrow transplantation she developed severe haemolytic anaemia and thrombocytopenia. This was resistant to standard therapies, including methylprednisolone, mycophenolate mofet...

ea0026s26.2 | The role of plasma binding proteins in tissue hormone delivery | ECE2011

The role of IGFBPs in the tissue-specific actions of IGFs

Holly J M P , Perks C M

The IGFs are present ubiquitously at very high levels throughout the body and affect virtually every aspect of cell function. These high levels are maintained due to their association with 6 distinct binding proteins (IGFBP-1 to -6) which specifically bind IGFs (but not insulin). The IGFs are not stored within any cells but are stored in the circulation due to their binding to IGFBP-3 which then results in its association with a large glycoprotein, the acid labile subunit (ALS...

ea0026p155 | Neuroendocrinology | ECE2011

Short-term balneotherapy is associated with changes in salivary cortisol levels

Matzer F , Bahadori B , Fazekas C

Since ancient times, physicians have speculated that balneotherapy (therapeutic bathing in medicinal and thermal springs) has a stress-relieving effect, but this has not yet been scientifically established. The aim of this study was to evaluate the stress-relieving effects of short-term balneotherapy in a controlled trial by measuring salivary cortisol as a sensitive stress marker. Forty-nine healthy probands were randomised into three intervention groups. Group one performed ...

ea0026p251 | Pituitary | ECE2011

Lost to follow-up in acromegaly, results of ACROSPECT observational study

Delemer B D , Reines C R , Brue T B , Rudelli C C Cortet , Raingeard I R , Reznik Y R , Parot X P , Chabre O C

Lost to follow-up (LTFU) is a frequent problem in chronic diseases not evaluated yet in acromegaly despite the long-term need of medical treatment and complications survey in this disease.Objectives: Evaluation of the prevalence of LTFU patients in a multi-center cohort, characteristics of defaulters and description of their evolution after they have been searched and found.Méthods: Observational multicentric (25 centers study...

ea0026p333 | Obesity | ECE2011

Investigating the role of FTO in obesity: dysregulation of satiety signalling

McMurray F , Church C , Cox R D

In 2007 a genome wide association study linked SNPs in intron 1 of FTO with an increased body mass index. Individuals with the ‘risk’ allele are on average 3 kg heavier than those with the ‘protective’ allele. Furthermore, those with the ‘risk’ allele have demonstrated greater energy intake. Mouse models of FTO have been generated including a conditional overexpression allele of FTO, which has 2 additional copies of FTO (FTO-4). These mice have in...

ea0026p401 | Thyroid (non cancer) | ECE2011

Parathyroid cyst, a rare cause of cystic thyroid lesion

Ghervan C , Goel P , Duncea I

Introduction: Parathyroid cyst is a very rare abnormality, representing 0.6% of all thyroid and parathyroid lesions. The diagnosis can be made on the basis of sonography and analysis of aspirated cystic fluid for parathyroid hormone. Parathyroid cysts are divided in two groups: functional (associated with clinical hyperparathyroidism) and non-functional. In the case of non-functional parathyroid cysts, fine needle aspiration is the elective treatment, but for functional parath...

ea0026p411 | Thyroid (non cancer) | ECE2011

Thyroid peroxidase antibodies in euthyroid children: is long term follow up required?

Tharian K , Evans C , Warner J T

Introduction: The presence of thyroid peroxidase (TPO) antibodies in euthyroid children poses a potential risk for the development of autoimmune hypothyroidism. Little is known about the ontogeny of this process. This retrospective study aims to estimate the risk of developing hypothyroidism in euthyroid children with raised TPO antibodies and provide a guideline for follow up.Methods: Children 0–16 years with raised TPO antibodies (1996–2005) ...